CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

February 26, 2025

Period of Report

February 25, 2025

Accession Number

0002007191-25-000029